BridgeMD
New treatment option for Spinal Cord Injuries
Official title Effect of Threshold Pressure-Loaded RMT + tTBS on Respiratory Function in SCI Patients
ClinicalTrials.gov ID: NCT07050069
What this study is testing
- What it's testing
- The purpose of this clinical trial is to understand whether threshold pressure load respiratory muscle training combined with iTBS can effectively improve the respiratory function of SCI patients. The main questions it aims to answer are: The impact of threshold pressure load respiratory muscle training on the respiratory function of SCI patients.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Patients with spinal cord injury (SCI) meeting the 2019 revised International Standards for Neurological Classification of Spinal Cord Injury by the...
- Aged 18-80 years.
- Time since injury: 2 weeks to 6 months, with spinal shock resolved.
- Injury level at T12 or above, ASIA Impairment Scale (AIS) grade A-C.
- Patients providing written informed consent after study explanation.
You likely can't join if
- Patients with severe cardiorespiratory diseases (e.g., pneumothorax).
- Unstable vital signs (e.g., hypotension, arrhythmia).
- Cognitive/psychiatric disorders precluding cooperation.
- Requiring mechanical ventilation.
- Congenital spinal/limb deformities.
- Contraindications to magnetic stimulation: intracranial metal implants, pacemakers, etc.
The study team makes the final eligibility decision.
Where it's taking place
- Shenyang, Liaoning, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shenyang, Liaoning, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.